Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 20;10(4):877.
doi: 10.3390/jcm10040877.

Thrombocytopenia in Virus Infections

Affiliations
Review

Thrombocytopenia in Virus Infections

Matthijs Raadsen et al. J Clin Med. .

Abstract

Thrombocytopenia, which signifies a low platelet count usually below 150 × 109/L, is a common finding following or during many viral infections. In clinical medicine, mild thrombocytopenia, combined with lymphopenia in a patient with signs and symptoms of an infectious disease, raises the suspicion of a viral infection. This phenomenon is classically attributed to platelet consumption due to inflammation-induced coagulation, sequestration from the circulation by phagocytosis and hypersplenism, and impaired platelet production due to defective megakaryopoiesis or cytokine-induced myelosuppression. All these mechanisms, while plausible and supported by substantial evidence, regard platelets as passive bystanders during viral infection. However, platelets are increasingly recognized as active players in the (antiviral) immune response and have been shown to interact with cells of the innate and adaptive immune system as well as directly with viruses. These findings can be of interest both for understanding the pathogenesis of viral infectious diseases and predicting outcome. In this review, we will summarize and discuss the literature currently available on various mechanisms within the relationship between thrombocytopenia and virus infections.

Keywords: HIV; SARS-CoV-2; aggregation; coronavirus; hantavirus; influenza; thrombocytopathy; thrombocytopenia; virus infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of PubMed search results.

References

    1. Sellers S.A., Hagan R.S., Hayden F.G., Fischer W.A., 2nd The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection. Influenza Other Respir. Viruses. 2017;11:372–393. doi: 10.1111/irv.12470. - DOI - PMC - PubMed
    1. Wasano K., Ishikawa T., Kawasaki T., Yamamoto S., Tomisato S., Shinden S., Minami S., Wakabayashi T., Ogawa K. Novel pre-therapeutic scoring system using patient and haematological data to predict facial palsy prognosis. Clin. Otolaryngol. 2017;42:1224–1228. doi: 10.1111/coa.12853. - DOI - PubMed
    1. Schirmer P.L., Wendelboe A., Lucero-Obusan C.A., Ryono R.A., Winters M.A., Oda G., Martinez M., Saavedra S., Holodniy M. Zika virus infection in the Veterans Health Administration (VHA), 2015–2016. PLoS Negl. Trop. Dis. 2018;12:e0006416. doi: 10.1371/journal.pntd.0006416. - DOI - PMC - PubMed
    1. Pakos I.S., Lo K.B., Salacup G., Pelayo J., Bhargav R., Peterson E., Gul F., DeJoy R., 3rd, Albano J., Patarroyo-Aponte G., et al. Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19. Eur. J. Haematol. 2020;105:773–778. doi: 10.1111/ejh.13509. - DOI - PMC - PubMed
    1. Martín-Rojas R.M., Pérez-Rus G., Delgado-Pinos V.E., Domingo-González A., Regalado-Artamendi I., Alba-Urdiales N., Demelo-Rodríguez P., Monsalvo S., Rodríguez-Macías G., Ballesteros M., et al. COVID-19 coagulopathy: An in-depth analysis of the coagulation system. Eur. J. Haematol. 2020;105:741–750. doi: 10.1111/ejh.13501. - DOI - PMC - PubMed

LinkOut - more resources